These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15104592)

  • 1. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
    Trang P; Kim K; Liu F
    Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General design and construction of RNase P ribozymes for gene-targeting applications.
    Zou H; Chan K; Trang P; Liu F
    Methods Mol Biol; 2004; 252():385-98. PubMed ID: 15017065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection of RNase P ribozymes that efficiently cleave a target mRNA.
    Kim K; Liu F
    Methods Mol Biol; 2004; 252():399-412. PubMed ID: 15017066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro construction of effective M1GS ribozymes targeting HCMV UL54 RNA segments.
    Su YZ; Li HJ; Li YQ; Chen HJ; Tang DS; Zhang X; Jiang H; Zhou TH
    Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):210-4. PubMed ID: 15756425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the regions of RNase P catalytic RNA that are potentially in close contact with its protein cofactor.
    Trang P; Liu F
    Methods Mol Biol; 2008; 488():267-77. PubMed ID: 18982298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
    Zhang W; Li X; Luo G; Huang Z; Liu Y
    Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering of RNase P ribozyme for gene-targeting applications.
    Raj SM; Liu F
    Gene; 2003 Aug; 313():59-69. PubMed ID: 12957377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1.
    Trang P; Kilani A; Kim J; Liu F
    J Mol Biol; 2000 Aug; 301(4):817-26. PubMed ID: 10966788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mRNAs by engineered sequence-specific RNase P ribozymes.
    Bai Y; Sunkara N; Liu F
    Methods Mol Biol; 2012; 848():357-68. PubMed ID: 22315080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
    Trang P; Kilani A; Lee J; Hsu A; Liou K; Kim J; Nassi A; Kim K; Liu F
    J Clin Virol; 2002 Aug; 25 Suppl 2():S63-74. PubMed ID: 12361758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells.
    Zou H; Lee J; Umamoto S; Kilani AF; Kim J; Trang P; Zhou T; Liu F
    J Biol Chem; 2003 Sep; 278(39):37265-74. PubMed ID: 12867424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNase P ribozyme as an antiviral agent against human cytomegalovirus.
    Trang P; Liu F
    Methods Mol Biol; 2004; 252():437-50. PubMed ID: 15017069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatitis C virus by an M1GS ribozyme derived from the catalytic RNA subunit of Escherichia coli RNase P.
    Mao X; Li X; Mao X; Huang Z; Zhang C; Zhang W; Wu J; Li G
    Virol J; 2014 May; 11():86. PubMed ID: 24885776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of RNase P Ribozyme Regions in Proximity with a Human RNase P Subunit Protein Using Fe(II)-EDTA Cleavage and Nuclease Footprint Analyses.
    Trang P; Smith A; Liu F
    Methods Mol Biol; 2023; 2666():55-67. PubMed ID: 37166656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.
    Kim K; Liu F
    Biochim Biophys Acta; 2007; 1769(11-12):603-12. PubMed ID: 17976837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of RNase P Ribozymes for Therapy against Human Cytomegalovirus Infection.
    Smith A; Zhang I; Trang P; Liu F
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bacterial RNase P RNA as a drug target.
    Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Amplification and Selection of Engineered RNase P Ribozyme for Gene Targeting Applications.
    Trang P; Zhang I; Liu F
    Methods Mol Biol; 2024; 2822():419-429. PubMed ID: 38907932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate.
    Trang P; Hsu AW; Liu F
    Nucleic Acids Res; 1999 Dec; 27(23):4590-7. PubMed ID: 10556315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.